A new global study estimates India faces the second-highest economic burden from diabetes, totaling $11.4 trillion, with the United States bearing the highest costs. The research, published in Nature Medicine, calculated the economic impact across 204 countries from 2020-2050. Global costs are around $10 trillion excluding informal care, but rise to $152 trillion when factoring in lost labor from caregivers. This highlights diabetes as a significant economic drain beyond its health implications.